Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies

Zambon4MDS 정보

Zambon App을 즐기십시오 : Zambon4MDS

Zambon describes itself as a “modern pharmaceutical multinational engaged day in, day out in the development of quality, innovative drugs intended to improve patients’ lives”. For us, being modern goes beyond innovation in drugs, being modern includes also coming up with ideas and tools that make our lives and those of the people that surround us better. In line with this statement Zambon has decided to invest in the creation of a mobile App dedicated to the 22nd International Congress of Parkinson's Disease and Movement Disorders, Hong Kong October 05th to 09th, 2018.

We have developed this App with the aim of facilitating your journey during this congress. We want to make sure that you take active part and you are updated with all the information and tools to make the best out of your participation to the 2018 MDS Congress.

In the App you will find useful information, the program of the congress, a dedicated chat where our logistics agency (NICO) will be connected to resolve any logistics difficulty that you might have during your visit and the agenda for the “Meet Expert” sessions organized by Zambon which will count with the presence of Prof. Angelo Antonini, Prof Werner Poewe and Dr. Javier Pagonabarraga at the Zambon Medical Corner – Booth.

번역 로드 중...

추가 앱 정보

최신 버전

Zambon4MDS 업데이트 요청 1.0

업로드한 사람

กรกต กันทะมาดา

필요한 Android 버전

Android 4.1+

Available on

Google Play에서 Zambon4MDS 얻기

더 보기

최신 버전 1.0의 새로운 기능

Last updated on Oct 26, 2018

Enjoy the new Zambon App: Zambon4MDS

더 보기

Zambon4MDS 스크린 샷

댓글 로드 중 ...
언어
APKPure를 구독하십시오
최고의 Android 게임 및 앱의 초기 릴리스, 뉴스 및 가이드에 액세스하는 첫 번째 사람이 되십시오.
고맙지 만 사양 할게
가입하기
성공적으로 구독!
당신은 이제 APKPure에 가입되었습니다.
APKPure를 구독하십시오
최고의 Android 게임 및 앱의 초기 릴리스, 뉴스 및 가이드에 액세스하는 첫 번째 사람이 되십시오.
고맙지 만 사양 할게
가입하기
성공!
당신은 이제 우리의 뉴스 레터를 구독하고 있습니다.